Free Trial

Vivid Seats (SEATW) Financials

$0.25 0.00 (0.00%)
As of 04/23/2025 03:48 PM Eastern
Annual Income Statements for Vivid Seats

Annual Income Statements for Vivid Seats

This table shows Vivid Seats' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
71 69 13
Consolidated Net Income / (Loss)
71 113 14
Net Income / (Loss) Continuing Operations
71 113 14
Total Pre-Tax Income
69 71 23
Total Operating Income
78 81 42
Total Gross Profit
460 531 574
Total Revenue
600 713 776
Operating Revenue
600 713 776
Total Cost of Revenue
141 182 202
Operating Cost of Revenue
141 182 202
Total Operating Expenses
382 449 532
Selling, General & Admin Expense
128 159 202
Marketing Expense
248 274 285
Depreciation Expense
7.73 17 44
Other Operating Expenses / (Income)
-2.07 -1.00 0.00
Total Other Income / (Expense), net
-8.92 -10 -20
Interest Expense
17 14 23
Other Income / (Expense), net
8.23 3.11 3.67
Income Tax Expense
-1.59 -42 8.42
Net Income / (Loss) Attributable to Noncontrolling Interest
29 75 9.43
Basic Earnings per Share
$0.36 $0.80 $0.07
Weighted Average Basic Shares Outstanding
80.26M 92.68M 132.33M
Diluted Earnings per Share
$0.36 $0.26 $0.06
Weighted Average Diluted Shares Outstanding
198.74M 198.88M 209.14M
Weighted Average Basic & Diluted Shares Outstanding
195.38M 210.18M 208.92M

Quarterly Income Statements for Vivid Seats

This table shows Vivid Seats' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
7.66 59 12 31 6.68 20 6.08 -1.06 5.30 3.12
Consolidated Net Income / (Loss)
19 25 30 14 18 52 13 -0.44 11 -8.76
Net Income / (Loss) Continuing Operations
19 33 30 38 16 29 11 -1.22 9.20 -4.42
Total Pre-Tax Income
19 32 31 14 19 7.93 13 -0.64 13 -3.13
Total Operating Income
22 25 34 18 20 10 21 7.88 11 2.90
Total Gross Profit
119 225 123 123 138 147 141 150 136 147
Total Revenue
157 296 161 165 188 198 191 198 187 200
Operating Revenue
157 - 161 165 188 198 191 198 187 200
Total Cost of Revenue
38 70 38 43 50 51 50 49 51 52
Operating Cost of Revenue
38 - 38 43 50 51 50 49 51 52
Total Operating Expenses
98 185 90 105 118 137 121 142 125 144
Selling, General & Admin Expense
30 61 32 38 37 51 42 61 46 52
Marketing Expense
66 - 55 65 77 77 68 70 68 79
Depreciation Expense
2.16 2.46 2.60 2.70 3.30 8.58 10 11 11 13
Total Other Income / (Expense), net
-2.84 -8.27 -2.95 -3.77 -1.51 -2.17 -7.66 -8.53 2.72 -6.04
Interest Expense
2.90 7.60 3.28 2.77 2.54 4.91 5.08 5.32 6.30 6.47
Other Income / (Expense), net
0.07 - 0.33 -1.00 1.04 2.74 -2.58 -3.20 9.02 0.43
Income Tax Expense
0.12 -1.71 0.29 -24 2.60 -21 2.27 0.58 4.29 1.28
Net Income / (Loss) Attributable to Noncontrolling Interest
11 3.17 18 31 6.68 19 4.67 -1.06 5.30 0.53
Basic Earnings per Share
$0.09 $0.13 $0.16 $0.36 $0.07 $0.21 $0.05 ($0.01) $0.04 ($0.01)
Weighted Average Basic Shares Outstanding
82.00M 80.26M 77.41M 85.27M 96.41M 92.68M 134.07M 131.80M 131.52M 132.33M
Diluted Earnings per Share
$0.09 $0.13 $0.15 $0.20 $0.07 ($0.16) $0.04 ($0.01) $0.04 ($0.01)
Weighted Average Diluted Shares Outstanding
82.02M 198.74M 195.82M 196.38M 96.86M 198.88M 210.91M 208.03M 131.95M 209.14M
Weighted Average Basic & Diluted Shares Outstanding
199.50M 195.38M 195.88M 196.18M 196.41M 210.18M 207.65M 208.08M 207.75M 208.92M

Annual Cash Flow Statements for Vivid Seats

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-238 -120 112
Net Cash From Operating Activities
14 147 54
Net Cash From Continuing Operating Activities
13 147 54
Net Income / (Loss) Continuing Operations
71 113 14
Consolidated Net Income / (Loss)
71 113 14
Depreciation Expense
7.73 17 44
Amortization Expense
1.05 0.92 0.99
Non-Cash Adjustments To Reconcile Net Income
18 25 52
Changes in Operating Assets and Liabilities, net
-85 -9.10 -58
Net Cash From Investing Activities
-15 -226 -27
Net Cash From Continuing Investing Activities
-15 -226 -27
Purchase of Property, Plant & Equipment
-3.56 -0.90 -4.23
Acquisitions
-0.01 -207 -0.35
Other Investing Activities, net
-12 -18 -22
Net Cash From Financing Activities
-236 -43 86
Net Cash From Continuing Financing Activities
-236 -43 86
Repayment of Debt
-4.86 -0.28 -2.97
Repurchase of Common Equity
-32 -20 -23
Payment of Dividends
-5.25 -14 -10
Issuance of Debt
275 0.00 0.00
Other Financing Activities, net
-469 -8.76 122
Effect of Exchange Rate Changes
0.00 1.90 -1.05
Cash Interest Paid
15 19 19
Cash Income Taxes Paid
0.00 4.02 5.47

Quarterly Cash Flow Statements for Vivid Seats

This table details how cash moves in and out of Vivid Seats' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-14 -22 52 2.88 -61 -114 31 81 -32 32
Net Cash From Operating Activities
-0.02 13 65 18 32 33 39 -14 -19 48
Net Cash From Continuing Operating Activities
0.00 11 65 -1.18 28 56 41 -13 -18 43
Net Income / (Loss) Continuing Operations
19 25 30 14 18 51 13 -0.44 11 -8.76
Consolidated Net Income / (Loss)
19 25 30 14 18 51 13 -0.44 11 -8.76
Depreciation Expense
2.16 2.46 2.60 8.01 -2.00 8.58 10 11 11 13
Amortization Expense
0.24 0.23 0.23 0.23 0.24 0.24 0.24 0.22 0.27 0.27
Non-Cash Adjustments To Reconcile Net Income
5.49 4.35 5.36 -16 31 4.66 11 21 2.08 18
Changes in Operating Assets and Liabilities, net
-27 -21 27 -7.10 -20 -9.06 6.26 -44 -41 21
Net Cash From Investing Activities
-4.96 -3.53 -2.61 -2.98 -65 -155 -5.29 -5.26 -7.29 -8.90
Net Cash From Continuing Investing Activities
-4.96 -3.53 -2.61 2.00 -70 -155 -5.29 -5.26 -7.29 -8.90
Purchase of Property, Plant & Equipment
-1.34 -0.83 -0.22 -0.39 -0.18 -0.11 -0.09 -0.29 -0.39 -3.46
Acquisitions
- - - - - -151 - - - -0.35
Other Investing Activities, net
-3.62 -2.70 -2.39 - - -3.57 -5.20 -4.98 -6.90 -5.10
Net Cash From Financing Activities
-8.66 -32 -11 -12 -4.19 -17 -4.61 99 -6.84 -1.80
Net Cash From Continuing Financing Activities
-8.66 -32 -11 1.81 -18 -17 -4.61 99 -6.84 -1.80
Repurchase of Common Equity
-3.05 -29 -7.61 - - -12 -3.11 -17 -2.93 0.02
Payment of Dividends
-5.61 1.05 - - - -3.29 - - -2.84 -0.76
Issuance of Debt
- - - - - - - - - -126
Other Financing Activities, net
- -3.17 -3.19 1.81 -6.69 -0.69 -1.23 -0.10 -1.07 124
Cash Interest Paid
3.60 4.91 1.94 5.32 5.99 6.08 6.07 10 0.62 2.77
Cash Income Taxes Paid
- - 0.00 0.40 - 3.62 0.62 2.66 1.86 0.33

Annual Balance Sheets for Vivid Seats

This table presents Vivid Seats' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
1,151 1,550 1,636
Total Current Assets
332 246 345
Cash & Equivalents
252 125 243
Restricted Cash
0.75 6.95 1.17
Accounts Receivable
37 58 48
Inventories, net
13 21 20
Prepaid Expenses
30 34 33
Plant, Property, & Equipment, net
10 10 13
Total Noncurrent Assets
809 1,294 1,278
Goodwill
715 947 943
Intangible Assets
82 241 233
Noncurrent Deferred & Refundable Income Taxes
0.00 86 78
Other Noncurrent Operating Assets
12 20 24
Total Liabilities & Shareholders' Equity
1,151 1,550 1,636
Total Liabilities
671 963 1,022
Total Current Liabilities
378 488 426
Short-Term Debt
2.75 3.93 3.95
Accounts Payable
161 258 233
Accrued Expenses
182 192 165
Current Deferred Revenue
32 35 24
Total Noncurrent Liabilities
293 476 596
Long-Term Debt
280 281 404
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 166 156
Other Noncurrent Operating Liabilities
13 29 37
Commitments & Contingencies
0.00 0.00 0.00
Redeemable Noncontrolling Interest
863 482 353
Total Equity & Noncontrolling Interests
-383 105 261
Total Preferred & Common Equity
-383 105 261
Total Common Equity
-383 105 261
Common Stock
664 1,096 1,268
Retained Earnings
-1,014 -940 -930
Treasury Stock
-32 -53 -76
Accumulated Other Comprehensive Income / (Loss)
0.00 0.75 -0.88

Quarterly Balance Sheets for Vivid Seats

This table presents Vivid Seats' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,181 1,228 1,325 1,385 1,589 1,655 1,611
Total Current Assets
364 408 428 406 297 371 326
Cash & Equivalents
274 303 306 269 154 234 202
Restricted Cash
0.51 0.68 0.67 1.06 6.85 6.14 6.19
Accounts Receivable
40 47 46 65 70 69 65
Inventories, net
14 24 28 22 30 30 22
Prepaid Expenses
35 33 47 49 37 32 30
Plant, Property, & Equipment, net
8.84 10 10 10 9.83 9.66 9.59
Total Noncurrent Assets
808 809 887 969 1,283 1,274 1,275
Goodwill
715 715 715 760 944 942 947
Intangible Assets
82 82 82 114 234 227 225
Noncurrent Deferred & Refundable Income Taxes
- - 79 77 85 85 81
Other Noncurrent Operating Assets
11 12 9.97 18 20 21 22
Total Liabilities & Shareholders' Equity
1,181 1,228 1,325 1,385 1,589 1,655 1,611
Total Liabilities
701 723 828 865 993 1,061 999
Total Current Liabilities
405 431 429 454 525 470 413
Short-Term Debt
2.75 2.75 2.75 3.31 3.58 3.95 3.95
Accounts Payable
165 218 204 219 307 267 224
Accrued Expenses
204 184 192 197 181 169 160
Current Deferred Revenue
34 26 30 34 33 30 25
Total Noncurrent Liabilities
295 292 399 411 468 591 586
Long-Term Debt
279 279 279 282 280 403 402
Noncurrent Deferred & Payable Income Tax Liabilities
- - 99 99 160 162 162
Other Noncurrent Operating Liabilities
16 13 21 30 28 26 23
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
905 902 790 641 457 438 282
Total Equity & Noncontrolling Interests
-425 -397 -293 -120 140 156 329
Total Preferred & Common Equity
-425 -397 -293 -120 140 156 329
Total Common Equity
-425 -397 -293 -120 140 156 329
Common Stock
602 645 718 885 1,130 1,164 1,334
Retained Earnings
-1,024 -1,002 -971 -965 -934 -935 -929
Treasury Stock
-3.05 -40 -40 -40 -57 -73 -76
Accumulated Other Comprehensive Income / (Loss)
- - - -0.17 -0.38 -1.22 0.77

Annual Metrics and Ratios for Vivid Seats

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
35.49% 18.76% 8.80%
EBITDA Growth
16.03% 7.81% -11.15%
EBIT Growth
14.83% -2.18% -45.66%
NOPAT Growth
49.07% 62.35% -79.51%
Net Income Growth
470.01% 59.85% -87.36%
EPS Growth
1,000.00% -27.78% -76.92%
Operating Cash Flow Growth
-91.82% 924.83% -63.40%
Free Cash Flow Firm Growth
-116.90% -183.73% 88.54%
Invested Capital Growth
29.01% 44.80% 5.13%
Revenue Q/Q Growth
21.88% -12.03% 0.20%
EBITDA Q/Q Growth
-10.40% -5.03% -5.66%
EBIT Q/Q Growth
-12.70% -12.03% -17.16%
NOPAT Q/Q Growth
-18.31% 8.41% -61.54%
Net Income Q/Q Growth
52.93% 30.94% -80.83%
EPS Q/Q Growth
89.47% -52.73% 166.67%
Operating Cash Flow Q/Q Growth
137.75% 15.66% 38.02%
Free Cash Flow Firm Q/Q Growth
0.00% -238.80% 94.43%
Invested Capital Q/Q Growth
4.72% 37.94% -3.89%
Profitability Metrics
- - -
Gross Margin
76.59% 74.44% 73.97%
EBITDA Margin
15.85% 14.39% 11.75%
Operating Margin
13.01% 11.41% 5.44%
EBIT Margin
14.38% 11.85% 5.92%
Profit (Net Income) Margin
11.79% 15.87% 1.84%
Tax Burden Percent
102.30% 159.48% 62.95%
Interest Burden Percent
80.14% 84.01% 49.51%
Effective Tax Rate
-2.30% -59.48% 37.05%
Return on Invested Capital (ROIC)
17.64% 20.76% 3.51%
ROIC Less NNEP Spread (ROIC-NNEP)
-3,068.96% 2.60% -4.28%
Return on Net Nonoperating Assets (RNNOA)
-2.00% 0.45% -1.12%
Return on Equity (ROE)
15.63% 21.21% 2.38%
Cash Return on Invested Capital (CROIC)
-7.70% -15.84% -1.50%
Operating Return on Assets (OROA)
6.74% 6.25% 2.88%
Return on Assets (ROA)
5.53% 8.38% 0.90%
Return on Common Equity (ROCE)
-21.47% -5.52% 0.73%
Return on Equity Simple (ROE_SIMPLE)
-18.49% 107.74% 5.48%
Net Operating Profit after Tax (NOPAT)
80 130 27
NOPAT Margin
13.31% 18.20% 3.43%
Net Nonoperating Expense Percent (NNEP)
3,086.60% 18.16% 7.79%
Return On Investment Capital (ROIC_SIMPLE)
-79.79% 33.28% 3.97%
Cost of Revenue to Revenue
23.41% 25.56% 26.03%
SG&A Expenses to Revenue
21.26% 22.32% 26.06%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
63.58% 63.03% 68.53%
Earnings before Interest and Taxes (EBIT)
86 84 46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
95 103 91
Valuation Ratios
- - -
Price to Book Value (P/BV)
0.00 11.82 3.68
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00
Price to Revenue (P/Rev)
2.43 1.74 1.24
Price to Earnings (P/E)
20.57 17.88 71.64
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
4.86% 5.59% 1.40%
Enterprise Value to Invested Capital (EV/IC)
4.60 2.54 1.90
Enterprise Value to Revenue (EV/Rev)
3.91 2.63 1.91
Enterprise Value to EBITDA (EV/EBITDA)
24.70 18.29 16.22
Enterprise Value to EBIT (EV/EBIT)
27.21 22.21 32.20
Enterprise Value to NOPAT (EV/NOPAT)
29.41 14.46 55.59
Enterprise Value to Operating Cash Flow (EV/OCF)
163.44 12.73 27.41
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.59 0.49 0.66
Long-Term Debt to Equity
0.58 0.48 0.66
Financial Leverage
0.00 0.17 0.26
Leverage Ratio
2.83 2.53 2.65
Compound Leverage Factor
2.27 2.13 1.31
Debt to Total Capital
37.05% 32.68% 39.90%
Short-Term Debt to Total Capital
0.36% 0.45% 0.39%
Long-Term Debt to Total Capital
36.69% 32.22% 39.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
113.13% 55.27% 34.54%
Common Equity to Total Capital
-50.18% 12.05% 25.56%
Debt to EBITDA
2.97 2.78 4.47
Net Debt to EBITDA
0.32 1.49 1.79
Long-Term Debt to EBITDA
2.94 2.74 4.43
Debt to NOPAT
3.54 2.20 15.34
Net Debt to NOPAT
0.38 1.17 6.13
Long-Term Debt to NOPAT
3.50 2.17 15.19
Altman Z-Score
0.79 0.38 0.28
Noncontrolling Interest Sharing Ratio
237.32% 126.03% 69.51%
Liquidity Ratios
- - -
Current Ratio
0.88 0.50 0.81
Quick Ratio
0.76 0.38 0.69
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-35 -99 -11
Operating Cash Flow to CapEx
404.02% 16,460.34% 1,275.66%
Free Cash Flow to Firm to Interest Expense
-2.03 -7.33 -0.49
Operating Cash Flow to Interest Expense
0.84 10.91 2.33
Operating Cash Flow Less CapEx to Interest Expense
0.63 10.84 2.14
Efficiency Ratios
- - -
Asset Turnover
0.47 0.53 0.49
Accounts Receivable Turnover
16.52 15.01 14.52
Inventory Turnover
11.44 10.78 9.94
Fixed Asset Turnover
104.28 69.26 68.26
Accounts Payable Turnover
0.80 0.87 0.82
Days Sales Outstanding (DSO)
22.09 24.32 25.13
Days Inventory Outstanding (DIO)
31.89 33.86 36.72
Days Payable Outstanding (DPO)
457.86 419.55 443.47
Cash Conversion Cycle (CCC)
-403.88 -361.37 -381.61
Capital & Investment Metrics
- - -
Invested Capital
510 739 777
Invested Capital Turnover
1.33 1.14 1.02
Increase / (Decrease) in Invested Capital
115 229 38
Enterprise Value (EV)
2,349 1,875 1,478
Market Capitalization
1,456 1,241 962
Book Value per Share
($1.92) $0.53 $1.26
Tangible Book Value per Share
($5.91) ($5.52) ($4.41)
Total Capital
763 872 1,022
Total Debt
283 285 408
Total Long-Term Debt
280 281 404
Net Debt
30 152 163
Capital Expenditures (CapEx)
3.56 0.90 4.23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-296 -370 -321
Debt-free Net Working Capital (DFNWC)
-44 -238 -77
Net Working Capital (NWC)
-46 -242 -81
Net Nonoperating Expense (NNE)
9.12 17 12
Net Nonoperating Obligations (NNO)
30 152 163
Total Depreciation and Amortization (D&A)
8.78 18 45
Debt-free, Cash-free Net Working Capital to Revenue
-49.32% -51.94% -41.43%
Debt-free Net Working Capital to Revenue
-7.29% -33.36% -9.88%
Net Working Capital to Revenue
-7.75% -33.91% -10.39%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.36 $0.80 $0.07
Adjusted Weighted Average Basic Shares Outstanding
80.26M 92.68M 132.33M
Adjusted Diluted Earnings per Share
$0.36 $0.26 $0.06
Adjusted Weighted Average Diluted Shares Outstanding
198.74M 198.88M 209.14M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
195.38M 210.18M 208.92M
Normalized Net Operating Profit after Tax (NOPAT)
55 57 27
Normalized NOPAT Margin
9.11% 7.99% 3.43%
Pre Tax Income Margin
11.53% 9.95% 2.93%
Debt Service Ratios
- - -
EBIT to Interest Expense
5.04 6.25 1.98
NOPAT to Interest Expense
4.66 9.61 1.15
EBIT Less CapEx to Interest Expense
4.83 6.19 1.80
NOPAT Less CapEx to Interest Expense
4.45 9.54 0.96
Payout Ratios
- - -
Dividend Payout Ratio
7.41% 12.64% 70.02%
Augmented Payout Ratio
53.32% 30.40% 230.71%

Quarterly Metrics and Ratios for Vivid Seats

This table displays calculated financial ratios and metrics derived from Vivid Seats' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
12.38% 57.32% 0.00% 11.97% 19.97% -32.95% 18.50% 19.92% -0.81% 0.76%
EBITDA Growth
37.14% -41.23% 137.53% -13.52% -19.77% -21.13% -21.41% -38.02% 58.42% -25.24%
EBIT Growth
40.68% -45.65% 146.63% -37.92% -2.80% -48.14% -46.53% -71.83% -6.48% -74.05%
NOPAT Growth
99.12% 11.05% 245.66% 172.05% -19.71% 39.15% -48.58% -88.69% -57.60% -94.41%
Net Income Growth
1,115.76% 7,560.49% 864.69% -43.28% -5.80% 107.70% -57.49% -103.20% -39.85% -116.99%
EPS Growth
0.00% 425.00% 650.00% 66.67% -22.22% -223.08% -73.33% -105.00% -42.86% 93.75%
Operating Cash Flow Growth
-100.05% 132.90% 176.67% 179.35% 186,664.71% 153.61% -39.85% -178.63% -160.61% 45.10%
Free Cash Flow Firm Growth
97.28% 0.00% 85.97% 105.70% -158.02% -116.92% -304.40% -1,256.82% -754.61% 81.34%
Invested Capital Growth
7.40% 29.01% 22.09% 5.43% 9.92% 44.80% 48.89% 61.19% 50.89% 5.13%
Revenue Q/Q Growth
6.18% 88.60% -45.54% 2.68% 13.76% 5.41% -3.76% 3.91% -5.91% 7.08%
EBITDA Q/Q Growth
-15.88% 13.59% 33.54% -32.23% -21.96% 11.65% 33.07% -46.55% 99.49% -47.31%
EBIT Q/Q Growth
-18.66% 13.74% 36.68% -50.90% 27.35% -39.31% 40.91% -74.13% 322.78% -83.16%
NOPAT Q/Q Growth
20.29% 21.01% 27.22% 46.91% -64.50% 109.72% -52.99% -67.68% 33.06% -72.33%
Net Income Q/Q Growth
-22.02% 32.30% 21.97% -54.92% 29.50% 191.71% -75.03% -103.40% 2,532.49% -182.42%
EPS Q/Q Growth
-25.00% 44.44% 15.38% 33.33% -65.00% -328.57% 144.44% -125.00% 500.00% -125.00%
Operating Cash Flow Q/Q Growth
99.92% 76,488.24% 401.39% -73.03% 80.63% 3.84% 18.92% -135.25% -39.24% 348.58%
Free Cash Flow Firm Q/Q Growth
97.20% -636.93% 38.98% 145.22% -226.88% -519.54% -13.77% -29.35% 6.26% 86.47%
Invested Capital Q/Q Growth
8.97% 4.72% -5.46% -2.27% 13.61% 37.94% -2.79% 5.81% 6.35% -3.89%
Profitability Metrics
- - - - - - - - - -
Gross Margin
76.01% 76.17% 76.56% 74.23% 73.18% 74.11% 74.02% 75.41% 72.65% 73.74%
EBITDA Margin
15.41% 9.28% 22.76% 15.02% 10.31% 10.92% 15.10% 7.76% 16.46% 8.10%
Operating Margin
13.84% 8.37% 20.81% 10.65% 10.69% 5.09% 10.83% 3.97% 5.77% 1.45%
EBIT Margin
13.88% 8.37% 21.01% 10.05% 11.25% 6.47% 9.48% 2.36% 10.60% 1.67%
Profit (Net Income) Margin
11.96% 8.39% 18.80% 8.25% 9.39% 26.00% 6.74% -0.22% 5.70% -4.38%
Tax Burden Percent
99.45% 78.57% 99.07% 98.59% 94.94% 649.99% 98.92% 67.86% 78.82% 279.55%
Interest Burden Percent
86.67% 127.60% 90.31% 83.31% 87.98% 61.77% 71.91% -13.76% 68.16% -94.06%
Effective Tax Rate
0.63% -5.41% 0.93% -176.90% 13.94% -259.66% 17.44% 0.00% 31.81% 0.00%
Return on Invested Capital (ROIC)
14.39% 11.69% 35.75% 50.00% 14.58% 20.89% 11.06% 3.50% 4.53% 1.04%
ROIC Less NNEP Spread (ROIC-NNEP)
13.31% -419.96% 45.70% 248.25% 17.71% 37.58% 2.69% -4.96% 7.63% -5.80%
Return on Net Nonoperating Assets (RNNOA)
16.44% -0.27% -2.87% -9.22% 0.40% 6.43% 0.25% -0.64% 1.43% -1.52%
Return on Equity (ROE)
30.83% 11.42% 32.88% 40.78% 14.98% 27.33% 11.31% 2.86% 5.96% -0.48%
Cash Return on Invested Capital (CROIC)
0.00% -7.70% 2.69% 21.72% 13.93% -15.84% -19.29% -33.60% -30.29% -1.50%
Operating Return on Assets (OROA)
5.27% 3.93% 12.79% 6.14% 7.10% 3.42% 5.00% 1.23% 5.48% 0.81%
Return on Assets (ROA)
4.54% 3.94% 11.44% 5.05% 5.93% 13.72% 3.56% -0.11% 2.94% -2.13%
Return on Common Equity (ROCE)
-53.32% -15.68% -44.67% -30.72% -8.17% -7.11% -2.65% -0.36% 1.10% -0.15%
Return on Equity Simple (ROE_SIMPLE)
-10.88% 0.00% -24.65% -29.83% -71.84% 0.00% 68.61% 52.41% 22.65% 0.00%
Net Operating Profit after Tax (NOPAT)
22 26 33 49 17 36 17 5.52 7.34 2.03
NOPAT Margin
13.75% 8.82% 20.61% 29.49% 9.20% 18.31% 8.94% 2.78% 3.93% 1.02%
Net Nonoperating Expense Percent (NNEP)
1.08% 431.65% -9.95% -198.25% -3.13% -16.69% 8.37% 8.46% -3.10% 6.85%
Return On Investment Capital (ROIC_SIMPLE)
- -26.06% - - - 9.32% - - - 0.30%
Cost of Revenue to Revenue
23.99% 23.83% 23.44% 25.77% 26.82% 25.89% 25.98% 24.59% 27.35% 26.26%
SG&A Expenses to Revenue
19.28% 20.68% 20.11% 23.16% 19.79% 25.80% 22.20% 30.79% 24.82% 26.22%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
62.17% 62.70% 55.75% 63.58% 62.48% 69.02% 63.19% 71.44% 66.88% 72.28%
Earnings before Interest and Taxes (EBIT)
22 25 34 17 21 13 18 4.68 20 3.33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
24 27 37 25 19 22 29 15 31 16
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 11.82 9.02 7.66 2.34 3.68
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.11 2.43 1.96 1.99 1.55 1.74 1.70 1.54 0.99 1.24
Price to Earnings (P/E)
34.00 20.57 16.88 14.19 11.62 17.88 19.88 37.85 25.53 71.64
Dividend Yield
3.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.94% 4.86% 5.92% 7.05% 8.60% 5.59% 5.03% 2.64% 3.92% 1.40%
Enterprise Value to Invested Capital (EV/IC)
5.02 4.60 4.91 4.91 3.58 2.54 2.56 2.37 1.54 1.90
Enterprise Value to Revenue (EV/Rev)
4.97 3.91 3.11 2.97 2.36 2.63 2.47 2.32 1.61 1.91
Enterprise Value to EBITDA (EV/EBITDA)
23.05 24.70 21.99 20.37 17.74 18.29 19.41 21.10 12.93 16.22
Enterprise Value to EBIT (EV/EBIT)
24.74 27.21 24.22 23.74 19.95 22.21 26.75 31.68 22.54 32.20
Enterprise Value to NOPAT (EV/NOPAT)
25.02 29.41 23.92 18.66 16.01 14.46 15.30 22.02 18.07 55.59
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 163.44 42.37 24.22 15.04 12.73 15.14 19.98 31.97 27.41
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 200.96 23.21 26.87 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.59 0.59 0.56 0.57 0.55 0.49 0.48 0.68 0.66 0.66
Long-Term Debt to Equity
0.58 0.58 0.55 0.56 0.54 0.48 0.47 0.68 0.66 0.66
Financial Leverage
1.23 0.00 -0.06 -0.04 0.02 0.17 0.09 0.13 0.19 0.26
Leverage Ratio
6.16 2.83 2.67 2.67 2.56 2.53 2.56 2.73 2.65 2.65
Compound Leverage Factor
5.34 3.61 2.41 2.22 2.26 1.56 1.84 -0.38 1.80 -2.50
Debt to Total Capital
37.00% 37.05% 35.85% 36.15% 35.39% 32.68% 32.21% 40.63% 39.87% 39.90%
Short-Term Debt to Total Capital
0.36% 0.36% 0.35% 0.35% 0.41% 0.45% 0.41% 0.39% 0.39% 0.39%
Long-Term Debt to Total Capital
36.64% 36.69% 35.50% 35.80% 34.98% 32.22% 31.80% 40.23% 39.48% 39.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
118.84% 113.13% 114.66% 101.53% 79.54% 55.27% 51.92% 43.80% 27.73% 34.54%
Common Equity to Total Capital
-55.85% -50.18% -50.51% -37.68% -14.93% 12.05% 15.87% 15.57% 32.39% 25.56%
Debt to EBITDA
2.66 2.97 2.62 2.47 2.64 2.78 2.99 4.77 4.20 4.47
Net Debt to EBITDA
0.07 0.32 -0.20 -0.22 0.14 1.49 1.29 1.95 2.04 1.79
Long-Term Debt to EBITDA
2.63 2.94 2.59 2.45 2.61 2.74 2.95 4.72 4.16 4.43
Debt to NOPAT
2.88 3.54 2.85 2.27 2.38 2.20 2.36 4.98 5.87 15.34
Net Debt to NOPAT
0.08 0.38 -0.22 -0.21 0.13 1.17 1.02 2.03 2.85 6.13
Long-Term Debt to NOPAT
2.85 3.50 2.82 2.25 2.36 2.17 2.33 4.93 5.81 15.19
Altman Z-Score
0.54 0.61 0.78 0.73 0.49 0.22 0.27 0.29 0.11 0.19
Noncontrolling Interest Sharing Ratio
272.97% 237.32% 235.86% 175.33% 154.55% 126.03% 123.41% 112.60% 81.52% 69.51%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.90 0.88 0.95 1.00 0.89 0.50 0.57 0.79 0.79 0.81
Quick Ratio
0.78 0.76 0.81 0.82 0.73 0.38 0.43 0.65 0.65 0.69
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-12 -89 -54 24 -31 -192 -219 -283 -265 -36
Operating Cash Flow to CapEx
-1.27% 1,562.70% 30,284.19% 4,490.79% 17,718.44% 29,940.00% 42,570.65% -4,827.27% -4,941.90% 1,381.13%
Free Cash Flow to Firm to Interest Expense
-4.15 -11.67 -16.50 8.83 -12.20 -39.19 -43.06 -53.17 -42.12 -5.55
Operating Cash Flow to Interest Expense
-0.01 1.71 19.85 6.33 12.47 6.71 7.71 -2.59 -3.05 7.39
Operating Cash Flow Less CapEx to Interest Expense
-0.47 1.60 19.79 6.19 12.40 6.69 7.69 -2.65 -3.11 6.86
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.38 0.47 0.61 0.61 0.63 0.53 0.53 0.52 0.52 0.49
Accounts Receivable Turnover
10.42 16.52 15.15 17.18 15.39 15.01 12.78 13.50 11.90 14.52
Inventory Turnover
6.80 11.44 8.48 7.66 11.29 10.78 7.23 6.87 9.17 9.94
Fixed Asset Turnover
103.61 104.28 126.75 114.15 84.93 69.26 73.75 77.49 78.08 68.26
Accounts Payable Turnover
0.57 0.80 0.78 0.95 1.05 0.87 0.74 0.85 0.91 0.82
Days Sales Outstanding (DSO)
35.03 22.09 24.09 21.24 23.72 24.32 28.55 27.04 30.68 25.13
Days Inventory Outstanding (DIO)
53.66 31.89 43.05 47.66 32.32 33.86 50.48 53.12 39.81 36.72
Days Payable Outstanding (DPO)
638.17 457.86 465.22 383.15 348.55 419.55 494.37 429.20 403.19 443.47
Cash Conversion Cycle (CCC)
-549.48 -403.88 -398.08 -314.26 -292.51 -361.37 -415.34 -349.03 -332.69 -381.61
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
487 510 483 472 536 739 718 760 808 777
Invested Capital Turnover
1.05 1.33 1.73 1.70 1.58 1.14 1.24 1.26 1.15 1.02
Increase / (Decrease) in Invested Capital
34 115 87 24 48 229 236 289 273 38
Enterprise Value (EV)
2,447 2,349 2,371 2,316 1,916 1,875 1,838 1,798 1,249 1,478
Market Capitalization
1,534 1,456 1,491 1,551 1,260 1,241 1,259 1,194 770 962
Book Value per Share
($2.12) ($1.92) ($2.03) ($1.50) ($0.61) $0.53 $0.66 $0.75 $1.58 $1.26
Tangible Book Value per Share
($6.10) ($5.91) ($6.11) ($5.57) ($5.07) ($5.52) ($4.94) ($4.88) ($4.05) ($4.41)
Total Capital
762 763 787 779 806 872 879 1,001 1,017 1,022
Total Debt
282 283 282 281 285 285 283 407 405 408
Total Long-Term Debt
279 280 279 279 282 281 280 403 402 404
Net Debt
7.50 30 -22 -25 15 152 122 166 197 163
Capital Expenditures (CapEx)
1.34 0.83 0.22 0.39 0.18 0.11 0.09 0.29 0.39 3.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-313 -296 -324 -305 -315 -370 -386 -335 -291 -321
Debt-free Net Working Capital (DFNWC)
-38 -44 -20 1.47 -45 -238 -225 -95 -83 -77
Net Working Capital (NWC)
-41 -46 -23 -1.28 -49 -242 -228 -99 -87 -81
Net Nonoperating Expense (NNE)
2.80 1.28 2.93 35 -0.36 -15 4.20 5.95 -3.29 11
Net Nonoperating Obligations (NNO)
7.50 30 -22 -25 15 152 122 166 197 163
Total Depreciation and Amortization (D&A)
2.40 2.70 2.82 8.23 -1.77 8.81 11 11 11 13
Debt-free, Cash-free Net Working Capital to Revenue
-63.53% -49.32% -42.53% -39.20% -38.88% -51.94% -51.92% -43.23% -37.63% -41.43%
Debt-free Net Working Capital to Revenue
-7.82% -7.29% -2.60% 0.19% -5.59% -33.36% -30.26% -12.23% -10.70% -9.88%
Net Working Capital to Revenue
-8.38% -7.75% -2.96% -0.16% -6.00% -33.91% -30.74% -12.74% -11.21% -10.39%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.09 $0.13 $0.16 $0.36 $0.00 $0.21 $0.05 ($0.01) $0.04 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding
82.00M 80.26M 77.41M 85.27M 96.41M 92.68M 134.07M 131.80M 131.52M 132.33M
Adjusted Diluted Earnings per Share
$0.09 $0.13 $0.15 $0.20 $0.00 ($0.16) $0.04 ($0.01) $0.04 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding
82.02M 198.74M 195.82M 196.38M 0.00 198.88M 210.91M 208.03M 131.95M 209.14M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
199.50M 195.38M 195.88M 196.18M 196.41M 210.18M 207.65M 208.08M 207.75M 208.92M
Normalized Net Operating Profit after Tax (NOPAT)
22 17 33 12 17 7.07 17 5.52 7.34 2.03
Normalized NOPAT Margin
13.75% 5.86% 20.61% 7.46% 9.20% 3.56% 8.94% 2.78% 3.93% 1.02%
Pre Tax Income Margin
12.03% 10.68% 18.97% 8.37% 9.89% 4.00% 6.82% -0.32% 7.23% -1.57%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
7.50 3.26 10.32 5.99 8.32 2.62 3.56 0.88 3.14 0.52
NOPAT to Interest Expense
7.43 3.43 10.12 17.59 6.81 7.40 3.36 1.04 1.17 0.31
EBIT Less CapEx to Interest Expense
7.04 3.15 10.25 5.85 8.25 2.59 3.54 0.83 3.08 -0.02
NOPAT Less CapEx to Interest Expense
6.97 3.32 10.06 17.45 6.74 7.37 3.34 0.98 1.10 -0.22
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
613.60% 7.41% 0.00% 0.00% 11.54% 12.64% 0.00% 0.00% 16.81% 70.02%
Augmented Payout Ratio
613.60% 53.32% 40.96% 45.84% 54.42% 30.40% 16.28% 39.86% 64.36% 230.71%

Frequently Asked Questions About Vivid Seats' Financials

When does Vivid Seats's financial year end?

According to the most recent income statement we have on file, Vivid Seats' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Vivid Seats' net income changed over the last 2 years?

Vivid Seats' net income appears to be on a downward trend, with a most recent value of $14.30 million in 2024, falling from $70.78 million in 2022. The previous period was $113.14 million in 2023.

What is Vivid Seats's operating income?
Vivid Seats's total operating income in 2024 was $42.23 million, based on the following breakdown:
  • Total Gross Profit: $573.73 million
  • Total Operating Expenses: $531.51 million
How has Vivid Seats revenue changed over the last 2 years?

Over the last 2 years, Vivid Seats' total revenue changed from $600.27 million in 2022 to $775.59 million in 2024, a change of 29.2%.

How much debt does Vivid Seats have?

Vivid Seats' total liabilities were at $1.02 billion at the end of 2024, a 6.1% increase from 2023, and a 52.3% increase since 2022.

How much cash does Vivid Seats have?

In the past 2 years, Vivid Seats' cash and equivalents has ranged from $125.48 million in 2023 to $251.54 million in 2022, and is currently $243.48 million as of their latest financial filing in 2024.

How has Vivid Seats' book value per share changed over the last 2 years?

Over the last 2 years, Vivid Seats' book value per share changed from -1.92 in 2022 to 1.26 in 2024, a change of -165.5%.



This page (NASDAQ:SEATW) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners